A carregar...
Anti-drug antibody formation in Japanese Fabry patients following enzyme replacement therapy
Enzyme replacement therapy (ERT) for Fabry disease (deficiency of α-galactosidase A, α-Gal) with recombinant α-Gals (agalsidase alfa and agalsidase beta) is widely available and improves some of the clinical manifestations and biochemical findings. However, recent reports suggest that recurrent admi...
Na minha lista:
| Publicado no: | Mol Genet Metab Rep |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7548986/ https://ncbi.nlm.nih.gov/pubmed/33072516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgmr.2020.100650 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|